UCB, Pfizer sales and marketing update

Pfizer launched Toviaz fesoterodine 4 and 8 mg tablets in the U.S. for once-daily treatment of overactive bladder (OAB). The price is undisclosed. Pfizer has worldwide rights to the anti-muscarinic a...